Bolt Biotherapeutics (BOLT) IPO Opens 31% Higher

February 5, 2021 10:53 AM EST

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Today's IPO for Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) opened for trading at $26.10 after pricing 11,500,000 shares of common stock at a price to the public of $20.00 per share.

Morgan Stanley, SVB Leerink, Stifel and Guggenheim Securities are acting as joint bookrunners for the offering.

BOLT is a a clinical-stage immuno-oncology company



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Hot IPOs, IPOs

Related Entities

Stifel, Morgan Stanley, IPO, Guggenheim